Literature DB >> 1182121

Structure of the human erythrocyte blood group P1 glycosphingolipid.

M Naiki, J Fong, R Ledeen, D M Marcus.   

Abstract

A glycosphingolipid with blood group P1 activity was extracted from an acetone powder of human erythrocyte stroma with chloroform-methanol. It was purified by chromatography on columns of silicic acid and by preparative thin-layer chromatography of the fully acetylated and deacetylated glycolipid. The purified glycolipid contained galactose, N-acetylglucosamine, and glucose in a molar ratio of 3:1:1. Treatment of the P1 glycolipid with fig alpha-galactosidase released a single galactosyl residue and destroyed the blood group activity, and the alpha-galactosidase product had the same chromatographic mobility as paragloboside. Substitution sites on the neutral sugars of the P1 glycolipid and the alpha-galactosidase product were established by identification of methylated alditol acetates, and substitution on N-acetylglucosamine was determined by identification of methyl glycoside derivatives. The terminal nonreducing disaccharide of the P1 glycolipid is Gal(alpha, 1 leads to 4)Gal. N-Acetylglucosamine was identified as the next sugar in sequence by mass spectrometric analysis of the permethylated P1 glycolipid. On the assumption that the glucose residue is linked to ceramide, we propose the following structure for the P1 glycolipid: Gal(alpha, 1 leads to 4)Gal(beta, 1 leads to 4)Glc-NAc(beta, 1 leads to 4)Glc-Cer.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1182121     DOI: 10.1021/bi00693a009

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  16 in total

1.  Synthesis of the trisaccharide, 2-(p-trifluoroacetamidophenyl)ethyl O-alpha-D-galactopyranosyl-(1-4)-O-beta-D-galactopyranosyl-(1-4)-2-acet amido-2-deoxy-beta-D-glucopyranoside, corresponding to the blood group P1 determinant.

Authors:  S Nilsson; H Lönn; T Norberg
Journal:  Glycoconj J       Date:  1991-02       Impact factor: 2.916

2.  Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women. Evidence for placenta being the primary target for anti-Tja-antibodies.

Authors:  K Lindström; A E Von Dem Borne; M E Breimer; B Cedergren; Y Okubo; L Rydberg; S Teneberg; B E Samuelsson
Journal:  Glycoconj J       Date:  1992-12       Impact factor: 2.916

3.  Defects of glycosyltransferase activities in human fibroblasts of Pk and p blood group phenotypes.

Authors:  S Kijimoto-Ochiai; M Naiki; A Makita
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  Turtle-dove ovomucoid, a glycoprotein proteinase inhibitor with P1-blood-group antigen activity.

Authors:  C François-Gerard; C Gerday; J G Beeley
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

5.  Characterization of the specificity of binding of Moluccella laevis lectin to glycosphingolipids.

Authors:  S Teneberg; I Leonardsson; J Angström; S Ehrlich-Rogozinski; N Sharon
Journal:  Glycoconj J       Date:  1994-10       Impact factor: 2.916

6.  A single point mutation in the gene encoding Gb3/CD77 synthase causes a rare inherited polyagglutination syndrome.

Authors:  Anna Suchanowska; Radoslaw Kaczmarek; Maria Duk; Jolanta Lukasiewicz; Dorota Smolarek; Edyta Majorczyk; Ewa Jaskiewicz; Anna Laskowska; Kazimiera Wasniowska; Magdalena Grodecka; Elwira Lisowska; Marcin Czerwinski
Journal:  J Biol Chem       Date:  2012-09-10       Impact factor: 5.157

7.  Abnormalities in the glycosphingolipid content of human Pk and p erythrocytes.

Authors:  D M Marcus; M Naiki; S K Kundu
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

8.  Blood group glycosphingolipid expression in kidney of an individual with the rare blood group A1 Le(a-b+) p phenotype: absence of blood group structures based on the globoseries.

Authors:  K Lindström; P A Jovall; S Ghardashkani; B E Samuelsson; M E Breimer
Journal:  Glycoconj J       Date:  1996-04       Impact factor: 2.916

Review 9.  Future perspectives for glycolipid research in medicine.

Authors:  Timothy M Cox
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

10.  Host-specificity of uropathogenic Escherichia coli depends on differences in binding specificity to Gal alpha 1-4Gal-containing isoreceptors.

Authors:  N Strömberg; B I Marklund; B Lund; D Ilver; A Hamers; W Gaastra; K A Karlsson; S Normark
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.